News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Thazin Nwe Aung, PhD

Articles by Thazin Nwe Aung, PhD

The development of multimodal biomarkers may help predict response to immunotherapy among patients with melanoma and other malignancies.

Biomarker Expression Intensity Impacts Melanoma Treatment Decision-Making

ByThazin Nwe Aung, PhD

September 30th 2025

The development of multimodal biomarkers may help predict response to immunotherapy among patients with melanoma and other malignancies.

A machine learning method for scoring tumor-infiltrating lymphocytes may address variability in pathologist measurements.

Scaling Immune Cell Quantification in Melanoma Through AI-Driven Assessment

ByThazin Nwe Aung, PhD

September 29th 2025

A machine learning method for scoring tumor-infiltrating lymphocytes may address variability in pathologist measurements.

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)